COMMUNIQUÉS West-GlobeNewswire

Italian Achromatopsia Association Increases Global Awareness of Achromatopsia, a Rare Genetic Eye Disease, With an Expedition to Pingelap, the Island of the Color Blind
14/08/2019
TRENTO, Italy, Aug. 14, 2019 (GLOBE NEWSWIRE) -- The Italian Achromatopsia Association (IAA) today announced that it is organizing a trip to Pingelap, a remote Micronesian atoll in the South Pacific, also known as the “ [...]
Auxly Announces Signing Of Term Sheet For $84 Million Credit Facilities Through Its Joint Venture Partner, Sunens Farms Inc.
14/08/2019
VANCOUVER, British Columbia, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that its joint venture partner, Sunens Farms Inc. (“ Sunens [...]
Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results
14/08/2019
NEWTOWN, Pa., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on [...]
Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update
14/08/2019
– Additional patient dosed at 2E14 vg/kg in second cohort of IGNITE DMD trial – – Study protocol amended to expedite clinical execution of SGT-001 – – Recent $60M capital raise extends runway into the fourth quarter of [...]
Ogilvy Health Further Cultivates Creative Community With Multiple Promotions
14/08/2019
PARSIPPANY, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Ogilvy Health, part of Ogilvy ( www.ogilvy.com ), today announced the advancement of seven creative team members across the agency’s New Jersey and New York offices. [...]
Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
14/08/2019
IND Active for Phase 1/2 Trial of PR001 to Treat Parkinson’s Disease Patients with GBA1 Mutations Successful $125.0 Million Initial Public Offering Completed to Support Program Advancement and Expansion NEW YORK, Aug. [...]
PhaseBio Announces Receipt of Minutes of End-of-Phase 1 Meeting with the FDA and Alignment on a Single, Non-Randomized Phase 3 Trial to Support BLA Submission for PB2452
14/08/2019
Clinical development plan and Accelerated Approval regulatory path confirmed Phase 3 trial to initiate in the first quarter of 2020 and intended to support both major bleeding and surgery indications Conference call and [...]
Iterum Therapeutics Reports Second Quarter 2019 Financial Results
14/08/2019
--Phase 3 Topline Data anticipated in the fourth quarter-- -- NDA filings expected in first quarter of 2020-- DUBLIN, Ireland and CHICAGO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a [...]
Adynxx Reports Second Quarter 2019 Financial Results
14/08/2019
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class therapeutics [...]
JSC Olainfarm will add senior level management with international experience in pharmacy. Lauris Macijevskis continues to work on the Board of JSC Olainfarm
14/08/2019
In order to strengthen the management team of JSC Olainfarm, the Supervisory Council has decided to appoint a new candidate with international experience in pharmacy for the position of the Chairman of the Board of JSC [...]
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
14/08/2019
Biohit Oyj Half Year Financial Report 14 August 2019 at 9:30 am local time (EET) SUMMARY January-June 2019 Net sales EUR 5.0 million (EUR 4.9 million) Net sales grew by 1% compared to H1/2018 Operative EBITDA EUR +0.4 [...]
Demant A/S: Interim Report 2019
14/08/2019
Company announcement no 2019-07 14 August 2019 Interim Report 2019 8% growth for the Group – recent product launches drive growth acceleration into H2 12% unit growth drives market share gains in hearing aid wholesale [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
13/08/2019
Company Release no. 13/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 13 August 2019 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]
Sonoma Pharmaceuticals Reports First Quarter FY 2020 Financial Results
13/08/2019
Strong Quarter-Over-Quarter Performance 26% Increase in U.S. Product Revenue 46% Increase in Dermatology Revenue 23% Reduction in Operating Expenses PETALUMA, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Sonoma [...]
Synergy CHC Corp. Announces Second Quarter 2019 Results
13/08/2019
Westbrook, Maine, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended June 30th, [...]
KemPharm Reports Second Quarter 2019 Results
13/08/2019
CELEBRATION, Fla., Aug. 13, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today reported its corporate and [...]
DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
13/08/2019
Phase Ib study of DM199 in Chronic Kidney Disease enrollment complete Encouraging early signals in mechanism biomarkers (NO and PGE2), Kidney function (eGFR) and urine albumin (UACR) Phase II CKD protocol submitted, [...]
Novan Takes Steps to Reduce Real Estate Footprint
13/08/2019
Company entered into negotiations with third party to transfer lease obligation Non-binding letter of intent signed 60-day exclusivity period to finalize details A successful transaction would lead to a reduction in [...]
Aeterna Zentaris Reports Second Quarter 2019 Financial and Operating Results
13/08/2019
CHARLESTON, S.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today reported its financial and operating results for the second quarter ended June 30, 2019. All Amounts are in U.S [...]

Pages